View Cart  

FDA Approves Supernus’ Epilepsy Drug Oxtellar XR

A A
The FDA has approved Supernus Pharmaceuticals’ Oxtellar XR as a once-daily therapy for epilepsy and the company plans to launch the drug next year. 

To View This Article:

Login

Buy This Article Now

Add this article to your cart for $25.00